Zenon® Alexa Fluor® 568 Mouse IgG2a Labeling Kit - Citations

Zenon® Alexa Fluor® 568 Mouse IgG2a Labeling Kit - Citations

View additional product information for Zenon® Alexa Fluor® 568 Mouse IgG2a Labeling Kit - Citations (Z25106)

Showing 3 product Citations

Citations & References
Abstract
A seed for Alzheimer amyloid in the brain.
AuthorsHayashi H, Kimura N, Yamaguchi H, Hasegawa K, Yokoseki T, Shibata M, Yamamoto N, Michikawa M, Yoshikawa Y, Terao K, Matsuzaki K, Lemere CA, Selkoe DJ, Naiki H, Yanagisawa K
JournalJ Neurosci
PubMed ID15152051
'A fundamental question about the early pathogenesis of Alzheimer''s disease (AD) concerns how toxic aggregates of amyloid beta protein (Abeta) are formed from its nontoxic soluble form. We hypothesized previously that GM1 ganglioside-bound Abeta (GAbeta) is involved in the process. We now examined this possibility using a novel monoclonal antibody ... More
Functional cross-interaction of the fragments produced by the cleavage of distinct adhesion G-protein-coupled receptors.
AuthorsSilva JP, Lelianova V, Hopkins C, Volynski KE, Ushkaryov Y,
JournalJ Biol Chem
PubMed ID19124473
'The unusual adhesion G-protein-coupled receptors (aGPCRs) contain large extracellular N-terminal domains, which resemble cell-adhesion receptors, and C-terminal heptahelical domains, which may couple to G-proteins. These receptors are cleaved post-translationally between these domains into two fragments (NTF and CTF). Using the aGPCR latrophilin 1, we previously demonstrated that the fragments behave ... More
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.
AuthorsRamirez A, Heimbach A, Gründemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C,
JournalNat Genet
PubMed ID16964263
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. ... More